Uveitis following administration of the protease inhibitor indinavir to a patient with AIDS.
Gariano
R F
RF
Department of Ophthalmology, Yale University School of Medicine, New Haven, Connecticut 06520-8061, USA.
Cooney
E L
EL
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D019469:Indinavir / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D014606:Uveitis, Anterior / Q000139:chemically induced*
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019469:Indinavir